Chronic News and Research

RSS

Aventis ships its influenza vaccine, Fluzone

Aventis began to ship its influenza vaccine (Fluzone(R), Influenza Virus Vaccine) today, meeting the company's goal to provide Fluzone vaccine to customers to allow health-care providers to plan successful immunization programs for the upcoming influenza season.

3 Aug 2004

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).

3 Aug 2004

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics has announced the initiation of a multi-center, multi- national Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate in chronic hepatitis B (HBV) infected patients.

3 Aug 2004

Connection between air pollution and cardiovascular disease

Researchers at the University of Washington will direct the largest study of its kind to explore the connection between air pollution and the No. 1 cause of death in the United States: cardiovascular disease.

2 Aug 2004

European recommended approval of Remicade for treatment of psoriatic arthritis

Committee for Medicinal Products for Human Use of the European Agency for the Evaluation of Medicinal Products has issued a positive opinion recommending approval of expanded labeling for REMICADE(R) (infliximab), in combination with methotrexate, for treatment of active and progressive psoriatic arthritis (PsA) in patients who have responded inadequately to disease modifying anti- rheumatic drugs (DMARDs).

2 Aug 2004

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.

2 Aug 2004

Clinical benefit for moderate-to-severe plaque psoriasis patients treated with Raptiva for 30 months

Genentech and XOMA have announced preliminary 30-month (120 weeks) results from an open-label study evaluating the safety and efficacy of long-term continuous treatment with RAPTIVA® (efalizumab) in adults with moderate-to-severe chronic plaque psoriasis.

2 Aug 2004

Negative side effects of iron for people with kidney disease

More than 20 million Americans– one in nine adults– have chronic kidney disease, and most don't even know it.

2 Aug 2004

Automated health databases can help physicians monitor chronic diseases like hypertension

Blood pressure readings recorded in a computerized database provide as much valid information on care as doctor’s notes, suggesting that automated health databases can help physicians monitor chronic diseases like hypertension, according to new research.

2 Aug 2004

Risk of pelvic inflammatory disease (PID) decreases with condom use

A multi-center study from the University of Pittsburgh's Graduate School of Public Health suggests that women wishing to decrease their risk of pelvic inflammatory disease (PID) should ensure that their sexual partners use condoms consistently.

31 Jul 2004

Tablets which help recovering alcoholics stay off the drink

The United States Food and Drug Administration has approved Campral (acamprosate calcium) tablets which help recovering alcoholics to stay of the drink. Campral is manufactured by Forest Laboratories and Merck of Darmstadt, Germany.

29 Jul 2004

Final push towards elimination of Leprosy

It currently affects over 1 million people in Africa, Asia, South America, and the Pacific; and WHO estimates that between 2 and 3 million individuals are permanently disabled as a result of it. Although all the registered cases are on treatment, it is estimated that during the period 2000–2005, about 2.5 million people affected by leprosy need to be detected and treated.

29 Jul 2004

Drug to fight virus from the herpes family in transplant patients moves forward in trials

A drug once considered for cancer chemotherapy is advancing in clinical trials to test its effectiveness in fighting a virus from the herpes family that threatens transplant patients.

29 Jul 2004

Botox for the treatment of severe underarm sweating

Botox, or botulinum toxin type A, is commonly known as a wrinkle treatment, but recently the U.S. Food and Drug Administration (FDA) also approved it for the treatment of severe underarm sweating, a debilitating condition called primary axillary hyperhidrosis.

29 Jul 2004

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.

28 Jul 2004

Distinct types of leg symptoms reported by patients with (PAD) peripheral arterial disease

The presence and severity of peripheral arterial disease, as measured by comparing blood pressures in the arm and leg, and the nature of the leg symptoms a patient experiences can be used to identify those at highest risk of decline in walking endurance, according to a study in the July 28 issue of JAMA, the Journal of the American Medical Association.

28 Jul 2004

Physical symptoms such as nausea and shortness of breath, may predict shorter survival for patients with terminal cancer

A new study published July 26, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, finds a patient's symptoms and results of quality of life assessments may provide important clues to an individual patient's prognosis. Psychosocial factors, such as anxiety or spiritual distress, did not predict shorter survival.

26 Jul 2004

The Internet has become the street corner for many drug users and traffickers

Operation Web Tryp investigated Internet websites distributing highly dangerous designer drug analogues under the guise of “research chemicals” primarily shipped to the U.S. from China and India. These websites are known to have thousands of customers worldwide.

26 Jul 2004

Epilepsy, new therapeutic possibilities

To date epilepsy research has mainly concentrated on the transmission of the nerve cell signals to what are known as the synapses.

23 Jul 2004

European launch of non-invasive, painless and radiation-free device for the diagnosis of internal organ diseases

Medex Screen Ltd. today announced the European launch of MedexTest - a revolutionary non-invasive, painless and radiation-free device for the diagnosis of internal organ diseases (cardiovascular system, endocrine systems, immune system, urogenital organs, digestive system, respiratory system, spine etc.).

22 Jul 2004

Chronic News and Research

Aventis ships its influenza vaccine, Fluzone

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Connection between air pollution and cardiovascular disease

European recommended approval of Remicade for treatment of psoriatic arthritis

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Clinical benefit for moderate-to-severe plaque psoriasis patients treated with Raptiva for 30 months

Negative side effects of iron for people with kidney disease

Automated health databases can help physicians monitor chronic diseases like hypertension

Risk of pelvic inflammatory disease (PID) decreases with condom use

Tablets which help recovering alcoholics stay off the drink

Final push towards elimination of Leprosy

Drug to fight virus from the herpes family in transplant patients moves forward in trials

Botox for the treatment of severe underarm sweating

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

Distinct types of leg symptoms reported by patients with (PAD) peripheral arterial disease

Physical symptoms such as nausea and shortness of breath, may predict shorter survival for patients with terminal cancer

The Internet has become the street corner for many drug users and traffickers

Epilepsy, new therapeutic possibilities

European launch of non-invasive, painless and radiation-free device for the diagnosis of internal organ diseases

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News